Virological and immunological factors associated with HIV-1 differential disease progression in HLA-B 58:01-positive individuals
about
HIV-1 Env C2-V4 diversification in a slow-progressor infant reveals a flat but rugged fitness landscapeRole of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis.Preexisting compensatory amino acids compromise fitness costs of a HIV-1 T cell escape mutation.Structured observations reveal slow HIV-1 CTL escape.Immune-mediated attenuation of HIV-1Genetic determinants of Nef-mediated CD4 and HLA class I down-regulation differences between HIV-1 subtypes B and C.Temporal association of HLA-B*81:01- and HLA-B*39:10-mediated HIV-1 p24 sequence evolution with disease progression.Intersubtype differences in the effect of a rare p24 gag mutation on HIV-1 replicative fitness.tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection.Rapid, complex adaptation of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progressionFunctional avidity: a measure to predict the efficacy of effector T cells?HIV-1 Tat and Viral Latency: What We Can Learn from Naturally Occurring Sequence Variations.Early evolution of human leucocyte antigen-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C-infected women.Cell-mediated anti-Gag immunity in pharmacologically induced functional cure of simian AIDS: a 'bottleneck effect'?
P2860
Q28487168-8906D65C-20C4-41D7-B51E-1FE2AC836F53Q34499377-6DBD4BAA-3C56-4C4B-8DDA-4DB027461C7AQ34686014-5C358AE3-A65E-4F8C-BB1A-B8EABC6D96A4Q35099081-4F3F7D85-99E1-4704-BB41-9FBB3A0A63D0Q35798108-A4ACAE71-97E2-4DEA-8394-0E4F53F7C388Q36322026-3E3482A4-FF61-4FB3-8088-78FBF48D7461Q36363854-96635BF2-F320-48AE-8C8F-6008B58C06B3Q36414578-5576ACD0-CCFB-47E5-995B-619F1320ED6DQ36827396-F48B0B37-4EA7-4CA6-92B7-C2C828A3C8D6Q37039116-FA431D94-AAFF-4AEC-BC0F-7A1202D151E7Q38066211-374F5CEF-7411-47B8-A5A0-4A6B78436D67Q39134277-CF2267E3-5A51-4E9C-97E6-238695584922Q40501405-93860E17-1932-47A2-A5AC-C2B47FDB44A2Q40853026-4AFDBE5D-9290-482C-BD8F-86F16AD087C4
P2860
Virological and immunological factors associated with HIV-1 differential disease progression in HLA-B 58:01-positive individuals
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Virological and immunological ...... A-B 58:01-positive individuals
@ast
Virological and immunological ...... A-B 58:01-positive individuals
@en
type
label
Virological and immunological ...... A-B 58:01-positive individuals
@ast
Virological and immunological ...... A-B 58:01-positive individuals
@en
prefLabel
Virological and immunological ...... A-B 58:01-positive individuals
@ast
Virological and immunological ...... A-B 58:01-positive individuals
@en
P2093
P2860
P50
P356
P1433
P1476
Virological and immunological ...... A-B 58:01-positive individuals
@en
P2093
C Williamson
D P Martin
D R Chopera
M Mlotshwa
P2860
P304
P356
10.1128/JVI.02543-10
P407
P50
P577
2011-05-25T00:00:00Z